Package 61314-624-94

Brand: cimerli

Generic: ranibizumab-eqrn
NDC Package

Package Facts

Identity

Package NDC 61314-624-94
Digits Only 6131462494
Product NDC 61314-624
Product ID 61314-624_0bfab18c-289a-42a1-b426-0fc2274a7a3e
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (61314-624-94) / .05 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-12-12
Brand cimerli
Generic ranibizumab-eqrn
Sample Package No

Linked Drug Pages (1)

CIMERLI ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVITREAL"], "spl_id": "0bfab18c-289a-42a1-b426-0fc2274a7a3e", "openfda": {"nui": ["N0000193542", "N0000193543"], "unii": ["ZL1R02VT79"], "rxcui": ["2612675", "2612681", "2612684", "2612687"], "spl_set_id": ["4b383d74-4830-4587-95f7-c32a39268df7"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Sandoz Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61314-624-94)  / .05 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "61314-624-94", "marketing_start_date": "20241212"}], "brand_name": "CIMERLI", "product_id": "61314-624_0bfab18c-289a-42a1-b426-0fc2274a7a3e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "61314-624", "generic_name": "ranibizumab-eqrn", "labeler_name": "Sandoz Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CIMERLI", "active_ingredients": [{"name": "RANIBIZUMAB", "strength": ".3 mg/.05mL"}], "application_number": "BLA761165", "marketing_category": "BLA", "marketing_start_date": "20241212", "listing_expiration_date": "20261231"}